Autopsy report · NCT05242146
GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year before it stopped.
- 12 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
- Sponsor type
- Industry
- Conditions
- CNS Lymphoma
- Interventions
- GB5121
- Participants
- 12
- Sites
- 16
- Countries
- Australia, Canada, France, Israel, New Zealand, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.